01 7Injectafer
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 410
2019 Revenue in Millions : 456
Growth (%) : -10
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 672
2020 Revenue in Millions : 407
Growth (%) : 78
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 404
2021 Revenue in Millions : 672
Growth (%) : -40
Main Therapeutic Indication : Hematology
Currency : USD
2023 Revenue in Millions : 340
2022 Revenue in Millions : 404
Growth (%) : -5
Main Therapeutic Indication : Blood Disorders
Currency : USD
2017 Revenue in Millions : 214
2016 Revenue in Millions : 291
Growth (%) : -27
Main Therapeutic Indication : Blood Disorders
Currency : USD
2018 Revenue in Millions : 387
2017 Revenue in Millions : 200
Growth (%) : 93%
Main Therapeutic Indication : Hematology
Currency : USD
2019 Revenue in Millions : 452
2018 Revenue in Millions : 400
Growth (%) : 13
LOOKING FOR A SUPPLIER?
